Stay updated on Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.

Latest updates to the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check23 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical study on inhaled treprostinil for pulmonary hypertension, including objectives, study design, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference31%
Stay in the know with updates to Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.